Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by pruritic, scaly, erythematous lesions, xerosis, and lichenification. Dupilumab, a monoclonal antibody targeting I‐ (IL)‐4 and IL‐13 signaling, is widely used to treat moderate to severe AD. We report a 22 year‐old male with a history of as...
Manar A. Alotaibi, S. Alhelal, Noura Alotaibi et al.· Case Reports in Dermatologic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.